92 related articles for article (PubMed ID: 17574851)
1. Synthesis and matrix metalloproteinase (MMP)-12 inhibitory activity of ageladine A and its analogs.
Ando N; Terashima S
Bioorg Med Chem Lett; 2007 Aug; 17(16):4495-9. PubMed ID: 17574851
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel ageladine A analogs showing more potent matrix metalloproteinase (MMP)-12 inhibitory activity than the natural product.
Ando N; Terashima S
Bioorg Med Chem Lett; 2009 Sep; 19(18):5461-3. PubMed ID: 19665375
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and matrix metalloproteinase-12 inhibitory activity of ageladine A analogs.
Ando N; Terashima S
Chem Pharm Bull (Tokyo); 2011; 59(5):579-96. PubMed ID: 21532196
[TBL] [Abstract][Full Text] [Related]
4. A one-pot synthesis and biological activity of ageladine A and analogues.
Shengule SR; Loa-Kum-Cheung WL; Parish CR; Blairvacq M; Meijer L; Nakao Y; Karuso P
J Med Chem; 2011 Apr; 54(7):2492-503. PubMed ID: 21413800
[TBL] [Abstract][Full Text] [Related]
5. Application of a 6pi-1-azatriene electrocyclization strategy to the total synthesis of the marine sponge metabolite ageladine A and biological evaluation of synthetic analogues.
Meketa ML; Weinreb SM; Nakao Y; Fusetani N
J Org Chem; 2007 Jun; 72(13):4892-9. PubMed ID: 17539689
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and anticancer activities of ageladine A and structural analogs.
Ma Y; Nam S; Jove R; Yakushijin K; Horne DA
Bioorg Med Chem Lett; 2010 Jan; 20(1):83-6. PubMed ID: 19948404
[TBL] [Abstract][Full Text] [Related]
7. Platinum complexes can inhibit matrix metalloproteinase activity: platinum-diethyl[(methylsulfinyl)methyl]phosphonate complexes as inhibitors of matrix metalloproteinases 2, 3, 9, and 12.
Sasanelli R; Boccarelli A; Giordano D; Laforgia M; Arnesano F; Natile G; Cardellicchio C; Capozzi MA; Coluccia M
J Med Chem; 2007 Jul; 50(15):3434-41. PubMed ID: 17583333
[TBL] [Abstract][Full Text] [Related]
8. Total synthesis of ageladine A, an angiogenesis inhibitor from the marine sponge Agelas nakamurai.
Meketa ML; Weinreb SM
Org Lett; 2006 Mar; 8(7):1443-6. PubMed ID: 16562912
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis, biological evaluation, and NMR studies of a new series of arylsulfones as selective and potent matrix metalloproteinase-12 inhibitors.
Nuti E; Panelli L; Casalini F; Avramova SI; Orlandini E; Santamaria S; Nencetti S; Tuccinardi T; Martinelli A; Cercignani G; D'Amelio N; Maiocchi A; Uggeri F; Rossello A
J Med Chem; 2009 Oct; 52(20):6347-61. PubMed ID: 19775099
[TBL] [Abstract][Full Text] [Related]
10. The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors.
Holmes IP; Gaines S; Watson SP; Lorthioir O; Walker A; Baddeley SJ; Herbert S; Egan D; Convery MA; Singh OM; Gross JW; Strelow JM; Smith RH; Amour AJ; Brown D; Martin SL
Bioorg Med Chem Lett; 2009 Oct; 19(19):5760-3. PubMed ID: 19703773
[TBL] [Abstract][Full Text] [Related]
11. Identification of an orally efficacious matrix metalloprotease 12 inhibitor for potential treatment of asthma.
Li W; Li J; Wu Y; Rancati F; Vallese S; Raveglia L; Wu J; Hotchandani R; Fuller N; Cunningham K; Morgan P; Fish S; Krykbaev R; Xu X; Tam S; Goldman SJ; Abraham W; Williams C; Sypek J; Mansour TS
J Med Chem; 2009 Sep; 52(17):5408-19. PubMed ID: 19725580
[TBL] [Abstract][Full Text] [Related]
12. A new total synthesis of the zinc matrixmetalloproteinase inhibitor ageladine A featuring a biogenetically patterned 6pi-2-azatriene electrocyclization.
Meketa ML; Weinreb SM
Org Lett; 2007 Mar; 9(5):853-5. PubMed ID: 17261003
[TBL] [Abstract][Full Text] [Related]
13. Concise total synthesis of the marine natural product ageladine A.
Shengule SR; Karuso P
Org Lett; 2006 Aug; 8(18):4083-4. PubMed ID: 16928079
[TBL] [Abstract][Full Text] [Related]
14. [Design, synthesis and activity evaluation of novel matrix metalloproteinases inhibitors based on the structure of enzyme].
Jia H; Guo YS; Ge YY; Wen H; Yang J; Yang XY; Du GH; Yang GZ
Yao Xue Xue Bao; 2007 Dec; 42(12):1271-81. PubMed ID: 18338640
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and QSAR studies of novel lysine derives as amino-peptidase N/CD13 inhibitors.
Wang Q; Chen M; Zhu H; Zhang J; Fang H; Wang B; Xu W
Bioorg Med Chem; 2008 May; 16(10):5473-81. PubMed ID: 18467109
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of new sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 Sep; 16(17):7932-8. PubMed ID: 18718763
[TBL] [Abstract][Full Text] [Related]
17. beta-N-Biaryl ether sulfonamide hydroxamates as potent gelatinase inhibitors: part 1. Design, synthesis, and lead identification.
Yang SM; Scannevin RH; Wang B; Burke SL; Wilson LJ; Karnachi P; Rhodes KJ; Lagu B; Murray WV
Bioorg Med Chem Lett; 2008 Feb; 18(3):1135-9. PubMed ID: 18086526
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and evaluation of novel sulfonyl pyrrolidine derivatives as matrix metalloproteinase inhibitors.
Cheng XC; Wang Q; Fang H; Tang W; Xu WF
Bioorg Med Chem; 2008 May; 16(10):5398-404. PubMed ID: 18440232
[TBL] [Abstract][Full Text] [Related]
19. Identification of MMP-12 inhibitors by using biosensor-based screening of a fragment library.
Nordström H; Gossas T; Hämäläinen M; Källblad P; Nyström S; Wallberg H; Danielson UH
J Med Chem; 2008 Jun; 51(12):3449-59. PubMed ID: 18494455
[TBL] [Abstract][Full Text] [Related]
20. Novel scaffold for cathepsin K inhibitors.
Teno N; Miyake T; Ehara T; Irie O; Sakaki J; Ohmori O; Gunji H; Matsuura N; Masuya K; Hitomi Y; Nonomura K; Horiuchi M; Gohda K; Iwasaki A; Umemura I; Tada S; Kometani M; Iwasaki G; Cowan-Jacob SW; Missbach M; Lattmann R; Betschart C
Bioorg Med Chem Lett; 2007 Nov; 17(22):6096-100. PubMed ID: 17911019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
